Activeted-348614-2026
Drug Discount Agreements for Follitropin alfa and Omalizumab
Conclusion of non-exclusive discount agreements for specific active ingredients, valid for two years from July 2026. Pharmaceutical companies are invited to join under uniform conditions.
CONTRACTING AUTHORITY
Name
spectrumK GmbH
City
Essen
Country
DE
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
LOTS (2)
LOT-0001Supplies
Rabattvertrag für Follitropin alfa
LOT-0002Supplies
Rabattvertrag für Omalizumab
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
allowed
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
16 days remaining(LOT-0001)
Published